Transforming growth factor beta 1 (TGF-β1) induces Foxp3+ regulatory T cells (Tregs) (4), and TGF-β1 from gastric tumors inhibits anti-tumor immunity in the tumor microenvironment via this mechanism (5, 6). Here, FOXP3 is linked to neoplasm.